David Fink Carl Zeiss MediTec, Code F (Financial Support), CenterVue, Code F (Financial Support), Heidelberg Engineering, Code F (Financial Support), Optos, Code F (Financial Support);
Frank Holz Acucela, Alexion, Alzheon, Allergan, Apellis, Astellas, Bayer, Boehringer-Ingelheim, Bioeq/Formycon, Roche/Genentech, Geuder, Graybug, Gyroscope, Heidelberg Engineering, IvericBio, Janssen, Kanghong, LinBioscience, Novartis, Oxurion, Pixium Vision, Oxurion, Stealth BioTherapeutics, Zeiss , Code C (Consultant/Contractor), Acucela, Allergan, Apellis, Bayer, Bioeq/Formycon, CenterVue, Roche/Genentech, Geuder, Heidelberg Engineering, IvericBio, NightStarX, Novartis, Optos, Pixium Vision, Oxurion, Zeiss, Code F (Financial Support), Grade reading Center, Code O (Owner);
Robert Finger Alimera, Apellis, Bayer, Böhringer-Ingelheim, Novartis, ODOS, Oxford Innovation, ProGenerika, Roche/Genentech, Code C (Consultant/Contractor), Biogen, CentreVue (now Icare), Heidelberg Engineering, Zeiss Meditec, Code F (Financial Support);
Jan Terheyden Carl Zeiss MedicTec, CenterVue, Heidelberg Engineering, Optos, Code F (Financial Support), Novartis, Okko, Code R (Recipient)